Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2023 | Odyssey Therapeutics | $100.0M Series C | Lorence Kim | OrbiMed, SR One, Third Rock Ventures, AB Magnitude Ventures Group, Alexandria Venture Investments, BlackMars Capital, Catalio Capital Management, Colt Ventures, Creacion Ventures, CU Healthcare Innovation Fund, Fidelity Management & Research Company, Foresite Capital, General Catalyst, Global BioAccess Fund, HBM Healthcare Investments, KB Investment, T. Rowe Price Associates, Walleye Capital, Woodline Partners |